Nyxoah (NASDAQ:NYXH) Upgraded by Cantor Fitzgerald to “Strong-Buy” Rating

Cantor Fitzgerald upgraded shares of Nyxoah (NASDAQ:NYXH) to a strong-buy rating in a research report released on Wednesday morning,Zacks.com reports.

Several other equities analysts have also commented on NYXH. Stifel Nicolaus dropped their target price on Nyxoah from $12.00 to $11.00 and set a “buy” rating for the company in a research note on Thursday, January 29th. Piper Sandler restated an “overweight” rating and issued a $9.00 price target (down from $12.00) on shares of Nyxoah in a report on Friday, November 14th. Finally, Weiss Ratings reiterated a “sell (d-)” rating on shares of Nyxoah in a report on Monday, December 29th. One research analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, Nyxoah currently has a consensus rating of “Moderate Buy” and a consensus price target of $11.67.

Nyxoah Trading Down 6.1%

NYXH stock traded down $0.24 during midday trading on Wednesday, hitting $3.70. The stock had a trading volume of 18,927 shares, compared to its average volume of 52,765. The company’s 50-day moving average price is $4.67 and its 200 day moving average price is $5.08. The company has a debt-to-equity ratio of 0.40, a current ratio of 1.70 and a quick ratio of 1.41. The firm has a market cap of $126.02 million, a PE ratio of -1.49 and a beta of 1.56. Nyxoah has a 12-month low of $3.66 and a 12-month high of $11.87.

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the business. Raymond James Financial Inc. raised its position in Nyxoah by 35.6% in the third quarter. Raymond James Financial Inc. now owns 12,762 shares of the company’s stock valued at $59,000 after purchasing an additional 3,353 shares during the period. Bank of America Corp DE boosted its position in shares of Nyxoah by 72.4% in the second quarter. Bank of America Corp DE now owns 7,866 shares of the company’s stock worth $59,000 after buying an additional 3,303 shares during the period. Citadel Advisors LLC acquired a new stake in shares of Nyxoah in the third quarter valued at about $98,000. Deutsche Bank AG raised its holdings in shares of Nyxoah by 40.0% during the 4th quarter. Deutsche Bank AG now owns 35,000 shares of the company’s stock valued at $161,000 after buying an additional 10,000 shares during the period. Finally, Shay Capital LLC purchased a new stake in shares of Nyxoah during the 2nd quarter valued at about $374,000.

Nyxoah Company Profile

Nyxoah SA, headquartered in Mont-Saint-Guibert, Belgium, is a medical technology company focused on neuromodulation therapies for sleep‐disordered breathing. Established in 2018, the company’s primary offering is the Genio® system, a minimally invasive bilateral hypoglossal nerve stimulator designed to treat moderate to severe obstructive sleep apnea (OSA). By electrically stimulating the genioglossus muscle, the device helps maintain airway patency during sleep, reducing apnea events and improving overall sleep quality.

The Genio system comprises a small, implantable stimulator positioned submentally and an external activation unit worn by the patient.